The introduction of the drug in the country is generating significant buzz within the healthcare community. This novel dual medication – targeting both GLP-1 and GIP areas – offers a seemingly significant option https://bpc157australia472220.illawiki.com/2695776/australia_s_retatrutide_australia_a_possible_fresh_hope_for_weight_control